EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)
Clinical trial NCT04509674 · COMPLETED
Trial details
- NCT number
- NCT04509674
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-16
- Primary completion
- 2023-11-05
- Enrollment
- 6522
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.